Robert Dzialo is an associate in the firm’s Technology group. Mr. Dzialo advises clients on a wide array of corporate matters, including mergers and acquisitions, venture capital financings, public securities offerings, corporate restructurings and other strategic transactions. He also represents a number of publicly traded companies and investment funds in ongoing SEC compliance matters. He joined Goodwin in 2014 and is a member of the firm’s hiring committee.

While attending law school, Mr. Dzialo served as a senior editor for the Boston College Law Review.

Areas of Practice
Domaines D’Expertise





Mr. Dzialo’s client representations include:

Mergers and Acquisitions

  • PillPack in its sale to
  • Padlock Therapeutics in its $600 million sale to Bristol-Meyers Squibb
  • Sqrrl Data in its sale to
  • in its sale to Facebook
  • RedBrick Health in its sale to Marlin Equity Partners
  • Continuum in its sale to Thoma Bravo
  • Handy Technologies in its sale to Angie’s List
  • PlumChoice in its sale to SquareTrade, a division of Allstate
  • Merchants Bancshares in its sale to Community Bank System in a transaction valued at $304 million
  • LoJack Corporation in its $135 million sale to CalAmp Corp.
  • Concert Pharmaceuticals in its sale of its Cystic Fibrosis Treatment to Vertex Pharmaceuticals for up to $250 million
  • Litéra in its sale to K1 Capital
  • Monotype in its acquisition of Olapic for $130 million
  • A venture capital firm in its portfolio company recapitalization and $150 million secondary purchase
  • The investor group in CENX in its sale to Ericsson

Private Financings

  • BridgeBio Pharma in its $300M million preferred equity financing led by KKR and Viking Global
  • Cybereason in its $100 million Series D preferred stock financing
  • Salsify in its $30 million Series C preferred stock financing
  • Handy Technologies in its $50 million Series C preferred stock financing
  • Varsity Tutors in its $50 million Series C preferred equity financing
  • A “‘Shark Tank”' investor in connection with investments appearing on “‘Shark Tank”’
  • Momofuku in its preferred equity financing with RSE Ventures

Public Offerings

  • Underwriters in Endurance International Group’s follow-on public offerings raising a total of $479 million
  • AMAG Pharmaceuticals in numerous follow-on equity offerings and its high-yield bond offering

In The News









J.D., 2014
Boston College
(magna cum laude)
B.A., 2010
James Madison University
(magna cum laude)



Get In Touch
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.

Unsere Kunden verlassen sich auf unsere erstklassige Beratung, vor allem im Hinblick auf komplexe Transaktionen und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Branchen, verwenden wir einen kooperativen und interdisziplinären Ansatz, um Fragen unserer Kunden auch in extremen Spezialsituationen einer Lösung zuzuführen. Sie wollen mehr erfahren? Kontaktieren Sie uns gerne.

Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.


Search Other Lawyers
Recherche par Pratique